Detalhe da pesquisa
1.
The current state of molecular testing in the treatment of patients with solid tumors, 2019.
CA Cancer J Clin
; 69(4): 305-343, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31116423
2.
mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers.
Breast Cancer Res
; 25(1): 131, 2023 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37904250
3.
Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
Stem Cells
; 39(5): 536-550, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33470499
4.
FASN inhibition as a potential treatment for endocrine-resistant breast cancer.
Breast Cancer Res Treat
; 187(2): 375-386, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33893909
5.
KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancer.
Breast Cancer Res Treat
; 185(2): 343-357, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33057995
6.
Differentiation of Brain Tumor Microvasculature From Normal Vessels Using Optical Coherence Angiography.
Lasers Surg Med
; 53(10): 1386-1394, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34130353
7.
BRCA1-associated R-loop affects transcription and differentiation in breast luminal epithelial cells.
Nucleic Acids Res
; 47(10): 5086-5099, 2019 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30982901
8.
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours.
Br J Cancer
; 122(11): 1630-1637, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32238921
9.
Stable Isotope Dilution LC-HRMS Assay To Determine Free SN-38, Total SN-38, and SN-38G in a Tumor Xenograft Model after Intravenous Administration of Antibody-Drug Conjugate (Sacituzumab Govitecan).
Anal Chem
; 92(1): 1260-1267, 2020 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31765123
10.
PELP1 signaling contributes to medulloblastoma progression by regulating the NF-κB pathway.
Mol Carcinog
; 59(3): 281-292, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31872914
11.
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
J Transl Med
; 16(1): 142, 2018 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29843811
12.
Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
J Transl Med
; 16(1): 179, 2018 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29958537
13.
Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design.
J Neurooncol
; 139(2): 469-478, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29846894
14.
Metabolomic signature of brain cancer.
Mol Carcinog
; 56(11): 2355-2371, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28618012
15.
Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors.
Invest New Drugs
; 35(2): 180-188, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27917453
16.
Hypoxia in astrocytic tumors and implications for therapy.
Neurobiol Dis
; 85: 227-233, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26094595
17.
Obesity-associated systemic interleukin-6 promotes pre-adipocyte aromatase expression via increased breast cancer cell prostaglandin E2 production.
Breast Cancer Res Treat
; 149(1): 49-57, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25476497
18.
VB-111: a novel anti-vascular therapeutic for glioblastoma multiforme.
J Neurooncol
; 124(3): 365-72, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26108658
19.
Fungal metabolite ophiobolin A as a promising anti-glioma agent: In vivo evaluation, structure-activity relationship and unique pyrrolylation of primary amines.
Bioorg Med Chem Lett
; 25(20): 4544-8, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26341136
20.
Flotillin-1 palmitoylation is essential for its stability and subsequent tumor promoting capabilities.
Oncogene
; 43(14): 1063-1074, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38374406